dc.contributor.author |
Tietze, Nicola |
|
dc.contributor.author |
Amaral, Teresa |
|
dc.contributor.author |
Martus, Peter |
|
dc.contributor.author |
Sinnberg, Tobias |
|
dc.contributor.author |
Garbe, Claus |
|
dc.contributor.author |
Forschner, Andrea Lydia |
|
dc.contributor.author |
Eigentler, Thomas |
|
dc.contributor.author |
Keim, Ulrike |
|
dc.date.accessioned |
2020-02-26T14:29:09Z |
|
dc.date.available |
2020-02-26T14:29:09Z |
|
dc.date.issued |
2019 |
|
dc.identifier.issn |
2051-1426 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/98391 |
|
dc.language.iso |
en |
en |
dc.publisher |
Bmc |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1186/s40425-019-0659-0 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.subject.ddc |
570 |
de_DE |
dc.title |
Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - results of a prospective biomarker study |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20190926111821_00566 |
|
utue.personen.roh |
Forschner, Andrea |
|
utue.personen.roh |
Battke, Florian |
|
utue.personen.roh |
Hadaschik, Dirk |
|
utue.personen.roh |
Schulze, Martin |
|
utue.personen.roh |
Weissgraeber, Stephanie |
|
utue.personen.roh |
Han, Chung-Ting |
|
utue.personen.roh |
Kopp, Maria |
|
utue.personen.roh |
Frick, Maximilian |
|
utue.personen.roh |
Klumpp, Bernhard |
|
utue.personen.roh |
Tietze, Nicola |
|
utue.personen.roh |
Amaral, Teresa |
|
utue.personen.roh |
Martus, Peter |
|
utue.personen.roh |
Sinnberg, Tobias |
|
utue.personen.roh |
Eigentler, Thomas |
|
utue.personen.roh |
Kelm, Ulrike |
|
utue.personen.roh |
Garbe, Claus |
|
utue.personen.roh |
Doecker, Dennis |
|
utue.personen.roh |
Biskup, Saskia |
|
dcterms.isPartOf.ZSTitelID |
Journal For Immunotherapy of Cancer |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 180 |
de_DE |
dcterms.isPartOf.ZS-Volume |
7 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |